LeMaitre Vascular (LMAT) CEO George W. LeMaitre Receives Dividend-Equivalent Awards

What Happened
George W. LeMaitre (Chairman, CEO and Director) was credited with seven dividend-equivalent awards on September 3, 2026. These awards total 71.418 shares (individual amounts: 4.673; 4.673; 7.988; 9.573; 11.685; 13.239; 19.587) and were recorded at $0.00 per share (derivative awards — no cash paid). These are dividend equivalents that accrued on previously granted restricted stock units (RSUs) and performance share units (PSUs); they vest proportionately with the underlying awards. This is an award/crediting event, not an open-market purchase or sale.

Key Details

• Transaction date: 2026-09-03; Form 4 filed: 2026-09-08 (appears timely).
• Price/consideration: $0.00 per share; total recorded value $0 (these are dividend-equivalent rights).
• Shares credited (by item / footnote):
  • 4.673 (F1) — dividend equivalents from RSU grant 12/12/2022
  • 4.673 (F2) — dividend equivalents from PSU grant 12/12/2022
  • 7.988 (F3) — dividend equivalents from RSU grant 12/08/2023
  • 9.573 (F4) — dividend equivalents from PSU grant 12/08/2023
  • 11.685 (F5) — dividend equivalents from RSU grant 12/06/2024
  • 13.239 (F6) — dividend equivalents from PSU grant 12/06/2024
  • 19.587 (F7) — dividend equivalents from RSU grant 12/10/2025
• Shares owned after transaction: not disclosed in the provided filing excerpt.
• Notable footnotes: each item is a dividend equivalent right that vests proportionately with the related RSU or PSU and represents the economic equivalent of one share.
• Filing timeliness: filed 5 calendar days after the transaction; with the U.S. Labor Day holiday (Sep 7) the filing date appears to meet the SEC’s two-business-day requirement.

Context
Dividend-equivalent rights are accruals tied to prior equity awards (RSUs/PSUs). They are derivative credits that mirror dividends and vest with the underlying awards; they are not a market purchase or sale and do not by themselves signal an insider buying or selling the company’s stock. For retail investors, such credits indicate ongoing equity compensation being delivered according to prior grant terms rather than a directional trade.